Home
overview

In response to continuing unmet need, there is a high number of novel drugs in the pain therapeutics pipeline. For those developing new drugs, it is important to consider what the future landscape is likely to look like at the time of launch and how this should inform current activities. Active participation in the workshop will be highly encouraged.

Delegates will be encouraged to consider how their drugs fit into a future pain therapeutics landscape and what action they should be considering now to maximise their chances of success.
 

Chief Executive Officer, Chief Scientific Officers, Chief Medical Officers, Managing Directors, CEO, Head of Department, Principal Research Scientists, Clinical lead, Clinical Operations in the following fields:

Pain and Migraine
Inflammation
Chronic Pain
Neuropathic Pain
Analgesic pre-clinical development
Anaesthesia and Pain Management
CNS clinical trials
Ion Channel Pharmacology
Pharmacology Intelligence
Translational science
Drug development
Exploratory development

Past Attendees include:

AiCure; Amgen; Analgesia Partnership; Apollo Therapeutics; AstraZeneca; Bayer; Bayer AG; biogen; Cara Therapeutics ; Centre for Human Drug Research; Centrexion Therapeutics Corp.; Chdr; Clermont Universit; Convergence Pharmaceuticals; Daiichi Sankyo Co. Ltd.; Daiichi Sankyo co.ltd; Eli Lilly and Company; ENSCCF Sigma Clermont; Eupraxia Pharmaceuticals Inc; Family Cottage Sydney; GlaxoSmithKline; Grunenthal; Grunenthal GmbH; Gsk; Innopain; Ipsen Innovation; J & JPRD; Kings College London; Lucideon; MD Biosciences; Merck & Co.; MRC Technology; Mundipharma International Limited; Mundipharma International Ltd; Mundipharma Research; Mundipharma Research GmbH & Co. KG; Mundipharma Research Ltd; Nektar Therapeutics; NeuroDigm; Novartis; Pharmaleads; Premier Research; Queens University Belfast; Queen's University Belfast; Transpharmation Ltd; University of Manchester; US Army Institute for Surgical Research; Zoetis

 

Workshop LEADER

keynote-img

Joanne Taylor

VP, Head of Neuroscience, Prescient Healthcare Group

Joanne, who has a PhD in developmental neuroscience from King’s College London, heads up Prescient’s neuroscience business. After completing a postdoctoral fellowship, she joined Eisai. Over her 18-year career there, she led global teams in the discovery of novel therapeutic strategies for neurological conditions. As Director of Strategic Research Planning, she led reviews of Eisai’s neuroscience portfolio to identify areas of major focus and investment. Since joining Prescient in 2011, Joanne has supported portfolio, clinical, regulatory and commercial strategies for a wide array of clients. She is a seasoned workshop moderator.
 

Prescient Healthcare Group

Prescient Healthcare Group is a specialty biopharmaceutical product strategy and decision support consultancy that helps our clients make better clinical and commercial decisions, resulting in improved outcomes for patients, customers and shareholders. From our offices in London, New York, San Francisco, New Delhi and Beijing, our three specialist practices provide decision support to various pharmaceutical functions (InflexionRx), develop strategies that make our clients’ assets stand out from the competition (VantageRx), and align cross-functional teams on product strategy (FusionRx).
 

Workshop programme

8:30 Registration & Coffee

9:00 Opening Remarks and Introdcutions

Joanne Taylor

Joanne Taylor, VP, Head of Neuroscience, Prescient Healthcare Group
View Bio

Elisavet Primpidou

Elisavet Primpidou, Associate Vice President, Prescient Healthcare Group
View Bio

9:10 Overview of the current pain therapeutics landscape

  • Current market
  • Drugs in development
  • Regulatory challenges
  • Current value propositions
     
  • Joanne Taylor

    Joanne Taylor, VP, Head of Neuroscience, Prescient Healthcare Group
    View Bio

    Elisavet Primpidou

    Elisavet Primpidou, Associate Vice President, Prescient Healthcare Group
    View Bio

    9:50 How is the pain therapeutics landscape likely to change in the next 3-5 years?

  • Novel mechanisms
  • Disruptive technologies
  • Regulatory changes
  • Future access requirements
  • Joanne Taylor

    Joanne Taylor, VP, Head of Neuroscience, Prescient Healthcare Group
    View Bio

    Elisavet Primpidou

    Elisavet Primpidou, Associate Vice President, Prescient Healthcare Group
    View Bio

    10:30 Morning Coffee

    11:00 How can drugs in development successfully differentiate in the future pain therapeutics market?

  • Critical success factors in the future market
  • Future stakeholders
  • Differentiated future value propositions
  • Joanne Taylor

    Joanne Taylor, VP, Head of Neuroscience, Prescient Healthcare Group
    View Bio

    Elisavet Primpidou

    Elisavet Primpidou, Associate Vice President, Prescient Healthcare Group
    View Bio

    11:40 Practical steps toward future success

  • Open discussion on practical steps to plan for success in the future pain therapeutics market
  • Joanne Taylor

    Joanne Taylor, VP, Head of Neuroscience, Prescient Healthcare Group
    View Bio

    Elisavet Primpidou

    Elisavet Primpidou, Associate Vice President, Prescient Healthcare Group
    View Bio

    12:20 Closing Remarks

    12:30 End of Workshop

    +

    FEATURED SPEAKERS

    Elisavet Primpidou

    Elisavet Primpidou

    Associate Vice President, Prescient Healthcare Group

    Elisavet Primpidou

    Associate Vice President, Prescient Healthcare Group
    Elisavet Primpidou

    Elisavet joined Prescient in 2008 and heads up our business development activities in Europe. She holds a PhD in molecular immunology from Brunel University, and an MSc in medical genetics and a BSc in biology from the Royal Holloway University of London. As a consultant to the pharmaceutical industry, Elisavet has gained extensive experience in various aspects of drug development and commercialization, strategic marketing and life cycle management, providing critical analysis and recommendations to brand teams supporting new and existing products in oncology, hematology, neuroscience and other areas. Elisavet uses her expertise in evidence gathering to identify key unmet needs, gaps in strategy, opportunities for differentiation and potential threats.

    Joanne Taylor

    VP, Head of Neuroscience, Prescient Healthcare Group
    Joanne Taylor

    Joanne, who has a PhD in developmental neuroscience from King’s College London, heads up Prescient’s neuroscience business. After completing a postdoctoral fellowship, she joined Eisai. Over her 18-year career there, she led global teams in the discovery of novel therapeutic strategies for neurological conditions. As Director of Strategic Research Planning, she led reviews of Eisai’s neuroscience portfolio to identify areas of major focus and investment. Since joining Prescient in 2011, Joanne has supported portfolio, clinical, regulatory and commercial strategies for a wide array of clients. She is a seasoned workshop moderator.
     

    VENUE

    Holiday Inn Kensington Forum

    97 Cromwell Road , London, United Kingdom

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    [Workshop A] - Programme

    Download

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Holiday Inn Kensington Forum

    97 Cromwell Road
    London SW7 4DN
    United Kingdom

    Holiday Inn Kensington Forum

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SMi.
    Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out